Breast Cancer

ctDNA informs management of metastatic breast cancer

Circulating tumour DNA (ctDNA) testing should be incorporated into the management of patients with metastatic breast cancer (mBC), according to Australian researchers. A prospective ctDNA testing program at the Peter MacCallum Cancer Centre, Melbourne, has shown the approach is feasible and valuable as a complement to standard tumour testing in newly diagnosed and established metastatic ...

Already a member?

Login to keep reading.

© 2021 the limbic